Search dm+d | This AMP cannot be matched against our prescribing data.
| Description | COVID-19 Vaccine Bimervax (recombinant, adjuvanted) 40micrograms/0.5ml dose emulsion for injection multidose vials (Hipra Human Health S.L.U.) |
| BNF code | 1404000ATBTAABH |
| Virtual Medicinal Product | Generic COVID-19 Vaccine Bimervax (recombinant, adjuvanted) 40micrograms/0.5ml dose emulsion for injection multidose vials |
| Name | COVID-19 Vaccine Bimervax (recombinant, adjuvanted) 40micrograms/0.5ml dose emulsion for injection multidose vials |
| Abbreviated name | COVID-19 Vaccine Bimervax 0.5ml inj multidose vials |
| Supplier | Hipra Human Health S.L.U. |
| Current licensing authority | Medicines - MHRA/EMA |
| Previous licensing authority | None |
| Reason for change of licensing authority | Licence Granted |
| Date of change of licensing authority | 3 Aug 2023 |
| EMA additional monitoring | ✓ |
| Parallel import | ✗ |
| Restrictions on availability | Restricted Availability |
| Licensed Route | |
|---|---|
| Licenced route | Intramuscular |
| Actual Medicinal Product Packs | |
| COVID-19 Vaccine Bimervax (recombinant, adjuvanted) 40micrograms/0.5ml dose emulsion for injection multidose vials (Hipra Human Health S.L.U.) 100 dose | |
| COVID-19 Vaccine Bimervax (recombinant, adjuvanted) 40micrograms/0.5ml dose emulsion for injection multidose vials (Hipra Human Health S.L.U.) 10 dose | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.